Bli medlem
Bli medlem

Du är här

2016-05-20

Vigmed: Vigmed Holding AB (publ) reschedules interim report

The Board of Directors of Vigmed Holding AB (publ) has decided to
reschedule the publication of the interim report for January -
September 2016. The company will publish the report on November 15,
2016.

The Board of Directors of Vigmed Holding AB (publ) has decided to
reschedule the publication of the interim report for January -
September 2016. The company will publish the report on November 15,
2016.

For further information contact:

Chairman of the board, Sten Dahlborg + 70 836 9419 or CEO, Henrik
Olsen +46 76 349 7364

Vigmed is a Swedish medical technology company whose mission is to
eliminate needlestick injuries and the associated risk of cross
infections with blood-borne infectious diseases by offering the
market unique needle-protected products. Vigmed is headquartered in
Helsingborg, Sweden. Vigmed's share is traded on NASDAQ OMX First
North in Stockholm (ticker VIG) and has approximately 5 600
shareholders. Remium Nordic AB is the Company's Certified Advisor.
Additional information about the company can be found on Vigmed's
website: www.vigmed.com/investor

-----------------------------------------------------------
http://news.cision.com/vigmed/r/vigmed-holding-ab--publ--reschedules-int...
http://mb.cision.com/Main/5831/2013609/518548.pdf

Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.